Music therapy to reduce anxiety in cancer patients during MRI scans
The Effects of Music Therapy on Improving Psychological States of Cancer Patients Undergoing MRI Scans and a Relevant Mediator
This study tests if music therapy can help cancer patients feel less anxious and more relaxed during MRI scans compared to standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Guangzhou Concord Cancer Center Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Trial ID | NCT06282887 on ClinicalTrials.gov |
What this trial studies
This study examines how music therapy can help alleviate anxiety, symptom distress, and promote relaxation in cancer patients undergoing MRI scans. Participants will be randomly assigned to either a control group receiving standard care or a music therapy group that includes music interventions. The study will collect both psychological ratings and physiological data, such as pulse and respiration rates, to evaluate the effectiveness of the music therapy protocol. Additionally, the relationship between patient engagement with the music and changes in their psychological states will be assessed.
Who should consider this trial
Good fit: Ideal candidates are cancer patients aged 18-60 who can communicate in Mandarin, Cantonese, or English and experience anxiety during MRI scans.
Not a fit: Patients with severe psychiatric disorders, cognitive impairments, or those requiring other interventions to complete the MRI may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce anxiety and improve the overall experience of cancer patients during MRI scans.
How similar studies have performed: Previous studies have shown that music therapy can effectively reduce anxiety in various medical settings, suggesting a positive outlook for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. The subject is diagnosed with cancer; 2. The subject is between 18- 60 years old; 3. The subject understands Mandarin, Cantonese, or English; 4. The subject did not use medication for sedatives, anxiolytics, and/or sleep aids; 5. The subject is awake without cognitive disorders; 6. the subject rates more than 0 on the 0-10 VAS for anxiety; 7. The subject has finished primary school level education. Exclusion Criteria: 1. The subject withdraws the MRI scan; 2. The subject needs other intervention(s) to complete the scan; 3. The subject has hearing and/or visual impairments; 4. The subject has a history of a severe somatic psychiatric disease or clinically diagnosed mental disorders.
Where this trial is running
Guangzhou, Guangdong
- GuangZhou Concord Cancer Center — Guangzhou, Guangdong, China (Recruiting)
Study contacts
- Study coordinator: Yinglan He
- Email: wing_____5@hotmail.com
- Phone: 18320739030
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.